AstraZeneca PLC (NASDAQ:AZN) is one of the best pharma stocks to invest in. AstraZeneca PLC (NASDAQ:AZN) received a rating update from JPMorgan on December 8, with the firm lifting the price target on the stock to 16,000 GBP from 14,000 GBP while maintaining an Overweight rating on the stock. The rating update came as part of rating adjustments by the firm in the European pharma group as part of its 2026 outlook. AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built on Innovation Meanwhile, Ast ...